© 2019 Kantum Pharma

Registered trademark of Kantum Pharma, Inc

November 5, 2019

Preclinical results support the therapeutic potential of KB-1801 for the prevention of Cardiac Surgery-Associated Acute Kidney Injury and advancement into clinical development.

CAMBRIDGE, Mass., November 4, 2019 - Kantum Pharma Inc., a biopharmaceutical company focused...

October 23, 2019

This week the Boston Biomedical Innovation Center (B-BIC) released a new web video that highlights their 'Commercialization Coaches' and other services in which B-BIC successfully differentiates from other grants. Kantum Pharma, dedicated to the prevention and treatmen...

Episode #20 of the Charged podcast

Dr. Sylvie Breton is a biophysicist with a passion for discovery. Her work has the potential to change medicine--she has found a method of diagnosing and treating acute kidney injury, which is often called the "silent killer" for its l...

Please reload

Recent Posts
Please reload